17 research outputs found
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome associated with COVID-19: An Emulated Target Trial Analysis.
RATIONALE: Whether COVID patients may benefit from extracorporeal membrane oxygenation (ECMO) compared with conventional invasive mechanical ventilation (IMV) remains unknown. OBJECTIVES: To estimate the effect of ECMO on 90-Day mortality vs IMV only Methods: Among 4,244 critically ill adult patients with COVID-19 included in a multicenter cohort study, we emulated a target trial comparing the treatment strategies of initiating ECMO vs. no ECMO within 7 days of IMV in patients with severe acute respiratory distress syndrome (PaO2/FiO2 <80 or PaCO2 ≥60 mmHg). We controlled for confounding using a multivariable Cox model based on predefined variables. MAIN RESULTS: 1,235 patients met the full eligibility criteria for the emulated trial, among whom 164 patients initiated ECMO. The ECMO strategy had a higher survival probability at Day-7 from the onset of eligibility criteria (87% vs 83%, risk difference: 4%, 95% CI 0;9%) which decreased during follow-up (survival at Day-90: 63% vs 65%, risk difference: -2%, 95% CI -10;5%). However, ECMO was associated with higher survival when performed in high-volume ECMO centers or in regions where a specific ECMO network organization was set up to handle high demand, and when initiated within the first 4 days of MV and in profoundly hypoxemic patients. CONCLUSIONS: In an emulated trial based on a nationwide COVID-19 cohort, we found differential survival over time of an ECMO compared with a no-ECMO strategy. However, ECMO was consistently associated with better outcomes when performed in high-volume centers and in regions with ECMO capacities specifically organized to handle high demand. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/)
Interest of the quantification of Thymidine Kinase by enzyme-labeled immunoassay in Chronic Lymphoid Leukemia.
Interest of the quantification of Thymidine Kinase by enzyme-labeled immunoassay in Chronic Lymphoid Leukemia.
Leucémie monoblastique aiguë congénitale : À propos d'un cas et diagnostic différentiel
La leucémie aiguë est une pathologie rare chez le nouveau-né. Elle entraîne cependant de nombreux problèmes tant pour le clinicien que pour le biologiste amené à la prendre en charge. Bien que d’étiologie inconnue, le développement d’une leucémie aiguë néonatale suggère un réarrangement chromosomique. Plusieurs réarrangements chromosomiques particuliers, courants en cas de leucémie congénitale, ont été identifiés impliquant fréquemment le gène MLL. Le diagnostic différentiel est malaisé et inclut différentes pathologies régulièrement retrouvées en période néo-natale. Nous rapportons le cas d’un nouveau-né développant une leucémie monoblastique aiguë une heure après sa naissance. La cytogénétique a révélé un réarrangement du gène MLL. L’enfant a été traitée selon le protocole ELAM 02. Malheureusement, elle a développé une défaillance multiviscérale quelques jours plus tard et est décédée à cinq semaine
Résultats d'une étude tricentrique sur le système INR : Intérêt d'un kit de contrôle et de calibration
Résultats d'une étude tricentrique sur le système INR : Intérêt d'un kit de contrôle et de calibration
Morphology, cytogenetics, and survival in myelodysplasia with del(20q) or ider(20q): a multicenter study.
Isochromosome of the long arm of chromosome 20 with interstitial loss of material [ider(20q)] is a rare cytogenetic abnormality reported in myelodysplastic syndrome (MDS), with neither specific morphological pattern nor clear prognostic significance. The aim of this retrospective multicentric study is to compare the peripheral blood and bone marrow morphology of MDS patients with ider(20q) (n = 13) and del(20q) (n = 21) and controls (n = 47) in order to investigate whether the ider(20q) harbors specific morphological features. The secondary objective is to compare the outcome of patients from both groups. This study performed on the largest cohort of MDS patients with ider(20q) is the first that identifies specific morphological features (hypogranulated and vacuolized neutrophils and neutrophil erythrophagocytosis) allowing the identification of this cytogenetic abnormality with high sensitivity (70%) and specificity (85.7%). Suspected ider(20q) by morphology should therefore support targeted FISH tests in case of non informative karyotype. This combined approach will allow a better estimation of the prevalence of this underdiagnozed entity. The overall survival and progression-free survival did not statistically differ in both groups. However, hypogranulated and vacuolized neutrophils were significantly associated with survival
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome Associated with COVID-19: An Emulated Target Trial Analysis
International audienc